KRYS
Closed
Krystal Biotech Inc
139.01
+1.55 (+1.13%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 137.46
Day's Range: 136.44 - 143.44
Send
sign up or login to leave a comment!
When Written:
84.39
Krystal Biotech Inc is a biotechnology company that focuses on developing gene therapies for rare dermatological diseases. The company was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
Krystal Biotech's lead product candidate is KB103, a gene therapy for the treatment of dystrophic epidermolysis bullosa (DEB), a rare genetic skin disorder. KB103 uses a proprietary gene therapy platform called Skin TARgeted Delivery (STAR-D), which aims to deliver therapeutic genes directly to the skin cells affected by the disease.
In addition to KB103, Krystal Biotech is also developing gene therapies for other rare dermatological diseases, including Netherton syndrome and ichthyosis.
The company has partnerships with academic institutions and pharmaceutical companies to further develop its gene therapy platform and expand its pipeline of product candidates. Krystal Biotech went public in August 2018 and is listed on the NASDAQ stock exchange under the ticker symbol KRYS.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Krystal Biotech's lead product candidate is KB103, a gene therapy for the treatment of dystrophic epidermolysis bullosa (DEB), a rare genetic skin disorder. KB103 uses a proprietary gene therapy platform called Skin TARgeted Delivery (STAR-D), which aims to deliver therapeutic genes directly to the skin cells affected by the disease.
In addition to KB103, Krystal Biotech is also developing gene therapies for other rare dermatological diseases, including Netherton syndrome and ichthyosis.
The company has partnerships with academic institutions and pharmaceutical companies to further develop its gene therapy platform and expand its pipeline of product candidates. Krystal Biotech went public in August 2018 and is listed on the NASDAQ stock exchange under the ticker symbol KRYS.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!